Triple
T22765024
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Felix Rohatyn |
E563098
|
entity |
| Predicate | boardMemberOf |
P10
|
FINISHED |
| Object | Warner-Lambert Company |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Warner-Lambert Company | Statement: [Felix Rohatyn, boardMemberOf, Warner-Lambert Company]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Warner-Lambert Company Context triple: [Felix Rohatyn, boardMemberOf, Warner-Lambert Company]
-
A.
Burroughs Wellcome Company
Burroughs Wellcome Company was a pioneering American pharmaceutical firm known for its significant contributions to drug research and development in the 20th century.
-
B.
Smith, Kline & French
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
-
C.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
D.
G. D. Searle & Company
G. D. Searle & Company was a major American pharmaceutical firm known for developing products such as the artificial sweetener aspartame (NutraSweet) before being acquired by Monsanto.
-
E.
Schering-Plough
Schering-Plough was a major American pharmaceutical company known for developing prescription medicines, vaccines, and consumer health products before its merger with Merck & Co.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Warner-Lambert Company Target entity description: Warner-Lambert Company was a major American pharmaceutical and consumer healthcare corporation best known for products like Listerine and for its acquisition by Pfizer in 2000.
-
A.
Burroughs Wellcome Company
Burroughs Wellcome Company was a pioneering American pharmaceutical firm known for its significant contributions to drug research and development in the 20th century.
-
B.
Smith, Kline & French
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
-
C.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
D.
G. D. Searle & Company
G. D. Searle & Company was a major American pharmaceutical firm known for developing products such as the artificial sweetener aspartame (NutraSweet) before being acquired by Monsanto.
-
E.
Schering-Plough
Schering-Plough was a major American pharmaceutical company known for developing prescription medicines, vaccines, and consumer health products before its merger with Merck & Co.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e24552e11c81909c2d61578a558bd7 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f17a80249c819091569e7b8d500b45 |
completed | April 29, 2026, 3:26 a.m. |
Created at: April 17, 2026, 3:26 p.m.